Amoxicillin-clavulanic acid therapy may be associated with severe side effects -- review of the literature.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Medical Research

• Publication date

  2001-04-20

• Fields of study

  Medicine

• Identifiers
  PMID 11309226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged severe cholestasis induced by oxacillin derivatives. A report on two cases.

  2009cited by this paper
• Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid

  2005cited by this paper
• Drug-induced liver diseases.

  2000cited by this paper
• Rapidly progressive cholestasis: An unusual reaction to amoxicillin/clavulanic acid therapy in a child.

  2000cited by this paper
• Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

  2000cited by this paper
• Sinus Tissue Pharmacokinetics After Oral Administration of Amoxicillin/Clavulanic Acid

  2000cited by this paper
• Amoxicillin/Clavulanate-Associated Hepatic Failure with Progression to Stevens–Johnson Syndrome

  1999cited by this paper
• Erythema Multiforme Secondary to Amoxicillin/Clavulanic Acid Exposure

  1999cited by this paper
• In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections.

  1999cited by this paper
• [Hepatotoxicity by amoxicillin/clavulanic acid: case report].

  1999cited by this paper
• Csae Report: Prolonged Cholestasis with Ductopenia After Administration of Amoxicillin/Clavulanic Acid

  1999cited by this paper
• HLA association of amoxicillin-clavulanate--induced hepatitis.

  1999cited by this paper
• An Unusual Case of Amoxicillin/Clavulanic Acid-Related Hepatotoxicity

  1998cited by this paper
• [Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].

  1998cited by this paper
• Hemorrhagic colitis due to amoxicillin/clavulanate and nasal decongestants?

  1997cited by this paper
• A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom

  1997cited by this paper
• Genetic predisposition to drug-induced hepatotoxicity.

  1997cited by this paper
• Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media.

  1997cited by this paper
• Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid

  1997cited by this paper
• Intrahepatic cholestasis without hepatitis induced by amoxycillin/clavulanic acid.

  1996cited by this paper
• [Hepatitis caused by the amoxicillin-clavulanic acid combination. An example of drug-induced biliary hepatotoxicity].

  1996cited by this paper
• Hepatotoxicity of antibiotics.

  1995cited by this paper
• [Acute pancreatitis associated with hepatotoxicity induced by amoxicillin-clavulanic acid].

  1995cited by this paper
• [Drug-induced hepatitis: epidemiologic, clinical, diagnostic and physiopathologic aspects in 1995].

  1995cited by this paper
• Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin).

  1995cited by this paper
• Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations.

  1995cited by this paper
• [Acute cholangitis caused by an amoxicillin-clavulanic acid combination].

  1995cited by this paper
• Risk factors for the development of amoxycillin‐clavulanic acid associated jaundice

  1995cited by this paper
• Hepatocellular-cholestatic liver injury due to amoxycillin-clavulanic acid combination

  1994cited by this paper
• Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.

  1994cited by this paper
• Amoxycillin-clavulanic acid-erythromycin cross-liver toxicity: a case report.

  1994cited by this paper
• The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs.

  1993cited by this paper
• [A case of cholestatic hepatitis secondary to clavulanic acid-amoxicillin drug combination therapy].

  1992cited by this paper
• [Augmentin hepatotoxicity: responsibility of clavulanic acid? Apropos of a case].

  1992cited by this paper
• Liver damage from flucloxacillin, cloxacillin and dicloxacillin.

  1992cited by this paper
• Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.

  1992cited by this paper
• Augmentin‐induced jaundice with a fatal outcome

  1992cited by this paper
• Intrahepatic cholestasis induced by amoxicillin/clavulanic acid (Augmentin): a report on two cases.

  1991cited by this paper
• Augmentin‐induced jaundice

  1991cited by this paper
• [Cholestatic hepatitis caused by amoxicillin-clavulanic acid].

  1991cited by this paper
• [Cholestatic hepatitis induced by the amoxicillin-clavulanic acid combination. A case and review of the literature].

  1990cited by this paper
• Criteria of drug-induced liver disorders. Report of an international consensus meeting.

  1990cited by this paper
• Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim‐sulfamethoxazole

  1990cited by this paper
• Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

  1990cited by this paper
• Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case.

  1990cited by this paper
• Amoxycillin/clavulanic acid induced cholestasis.

  1990cited by this paper
• [Hepatic cholestasis probably due to the combination of amoxicillin and clavulanic acid].

  1990cited by this paper
• [Erythema multiforme, aplasia, cholestatic hepatitis during treatment with Augmentin (amoxicillin + clavulanic acid)].

  1990cited by this paper
• Reversible liver injury possibly due to roxithromycin therapy.

  1990cited by this paper
• [Acute cholestatic hepatitis after ingestion of roxithromycin].

  1989cited by this paper
• Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium.

  1989cited by this paper
• Amoxicillin-clavulanate potassium-associated cholestasis.

  1989cited by this paper
• Amoxycillin/clavulanic acid (augmentin)-induced intrahepatic cholestasis

  1989cited by this paper
• Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin)

  1989cited by this paper
• Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation.

  1989cited by this paper
• Cloxacillin-induced cholestatic jaundice.

  1986cited by this paper
• Jaundice Associated with Cephalosporin Therapy

  1985cited by this paper
• Ticarcillin-clavulanic acid therapy in severe infections.

  1985cited by this paper
• Estrogen-induced cholestasis: clues to pathogenesis and treatment.

  1983cited by this paper
• Cholestatic jaundice and hematuria due to hypersensitivity to cefaclor in a child.

  1983cited by this paper
• Erythromycin estolate and jaundice.

  1983cited by this paper
• Cephalosporin-induced cholestatic jaundice.

  1982cited by this paper
• Amoxycillin/Clavulanic Acid: A Review of its Antibacterial Activity, Pharmacokinetics and Therapeutic Use

  1981cited by this paper
• Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim.

  1981cited by this paper
• Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis.

  1980cited by this paper
• Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.

  1980cited by this paper
• Cholestatic and hepatocellular injury associated with erythromycin esters

  1979cited by this paper
• Fatal multisystem toxicity after co-trimoxazole.

  1978cited by this paper
• Hepatitis from intravenous high-dose oxacillin therapy: findings in an adult inpatient population.

  1978cited by this paper
• Letter: Hepatic necrosis and trimethoprim-sulfamethoxazole.

  1975cited by this paper
• Liver damage and estrogen therapy of prostatic cancer. Case report.

  1972cited by this paper
• Hepatic effects of oral contraceptives.

  1967cited by this paper

• The role of oral amoxicillin/clavulanic acid in the treatment of osteomyelitis: a systematic review

  2026cites this paper
• An appraisal of the South African antibacterial plants and their computational bioprospection for putative leads against Staphylococcus aureus penicillin-binding protein 2a and beta-lactamase

  2025cites this paper
• Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports

  2024cites this paper
• Early Treatment of Lyme Disease Prompted by Histopathologic Analysis of the Abdomen of an Engorged Tick.

  2024cites this paper
• Effects of long-term exposure to amoxicillin residues on stress resistance and body compositions of Penaeus vannamei

  2023cites this paper
• Clavulanic Acid and its Potential Therapeutic Effects on the Central Nervous System.

  2023cites this paper
• Effects of long-term exposure to amoxicillin residues on stress resistance and body compositions of Penaeus vannamei

  2023cites this paper
• Effects of long-term exposure to amoxicillin residues on stress resistance and body compositions of Penaeus vannamei

  2023cites this paper
• CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function

  2022cites this paper
• Pharmaceutical and Pharmacological Evaluation of Amoxicillin after Solubility Enhancement Using the Spray Drying Technique

  2022cites this paper
• Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study

  2022cites this paper
• CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity

  2022cites this paper
• Quand évoquer une hépatite médicamenteuse chez l’enfant ?

  2022cites this paper
• Application of Nanoemulsion in Tuberculosis Treatment

  2022cites this paper
• Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects

  2021cites this paper
• Role of the Surgical Pathologist in Diagnosis of Drug-induced Liver Injury: Recognizing Specific Patterns of Drug Injury.

  2021cites this paper
• A retrospective case-controlled cohort study of inpatient drug induced liver injury: the RIDDLE study.

  2020cites this paper
• Delayed Presentation of Drug-Induced Hepatic Injury

  2020cites this paper
• Atlantoaxial Instability Resulting in Intractable Nausea in a Person with C5 Complete Spinal Cord Injury: A Case Report

  2019cites this paper
• Clinical data analysis of patients with drug and dietary supplement induced liver injury in Latvia

  2019cites this paper
• Role of Cinnamon Extract in the Protection against Amoxicillin/Clavulanate-Induced Liver Damage in Rats

  2019cites this paper
• Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report

  2019cites this paper
• Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin

  2019cites this paper
• Amoxicillin-Loaded Polymeric Nanoparticles of Less than 100 nm: Design, Preparation and Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus

  2019cites this paper
• Drug-induced liver injury

  2019cites this paper
• Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities.

  2018cites this paper
• Liver Injury due to Amoxicillin vs. Amoxicillin/Clavulanate: A Subgroup Analysis of a Drug-Induced Liver Injury Case-Control Study in Italy

  2017cites this paper
• Amoxicillin-Loaded Polymeric Nanoparticles of Less than 100 nm: Design, Preparation and Antimicrobial Activity Against Methicillin-Resistant Staphylococcus aureus

  2017cites this paper
• The Protective Effects of 18β-Glycyrrhetinic Acid on Helicobacter pylori-Infected Gastric Mucosa in Mongolian Gerbils

  2016cites this paper
• The Role of Chronic Exposure to Amoxicillin/Clavulanic Acid on the Developmental Enamel Defects in Mice

  2016cites this paper
• Risk factors for severe or fatal drug‐induced liver injury from amoxicillin–clavulanic acid

  2015cites this paper
• Approaches for Pediatric Developmental Drug-Induced Liver Injury

  2015cites this paper
• Flavonoid Glycosides of Polygonum capitatum Protect against Inflammation Associated with Helicobacter pylori Infection

  2015cites this paper
• Antibiotika in der Zahnmedizin

  2014cites this paper
• Drug-induced liver injury in children: A structured approach to diagnosis and management

  2014cites this paper
• Antibiotic induced liver injury: what about children?

  2013cites this paper
• Antiinfektive Therapie der Osteomyelitis

  2013cites this paper
• Hepatotoxicity of Antimicrobials and Antifungal Agents

  2013cites this paper
• Zahnärztliche Antibiotikaverordnungen

  2012cites this paper
• A developmental approach to drug-induced liver injury in newborns and children.

  2012cites this paper
• Hepatic injury to the newborn liver due to drugs.

  2012cites this paper
• [5 days Cefaclor vs. 10 days amoxicillin/clavulanate in the treatment of childhood streptococcal pharyngitis. Data from a randomized clinical trial].

  2012cites this paper
• Lesión pigmentada en la cavidad oral como resultado de la ingesta de amoxicilina con ácido clavulánico. Reporte de un caso clínico y revisión de literatura científica

  2012cites this paper
• Los antibióticos en odontología

  2011cites this paper
• БЕЗОПАСНОСТЬ И ПЕРЕНОСИМОСТЬ АНТИБИОТИКОВ В АМБУЛАТОРНОЙ ПРАКТИКЕ

  2011cites this paper
• Salmonellosis: The Diseases, Treatment, Prevention And Drug Resistance

  2011cites this paper
• Hepatic failure-induced hypogonadism in a prostate cancer patient.

  2010cites this paper
• Hepatitis tóxica tras tratamiento secuencial con cotrimoxazol, levofloxacino, doxiciclina y sertralina en paciente con infección respiratoria

  2010cites this paper
• [Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection].

  2010cites this paper
• The Characteristics and Clinical Outcome of Drug-induced Liver Injury: A Single-center Experience

  2010cites this paper
• Hepatotoxicity of Antibacterials: Pathomechanisms and Clinical Data

  2010cites this paper
• The Complex Clinical Picture of b-Lactam Hypersensitivity: Penicillins, Cephalosporins, Carbapenems, and Clavams

  2010cites this paper
• Corticosteroid Therapy in a Case of Severe Cholestasic Hepatitis Associated with Amoxicillin–Clavulanate

  2010influential citation
• UNIVERSIDADE FEDERAL DE SÃO CARLOS CENTRO DE CIÊNCIAS EXATAS E TECNOLÓGICAS PROGRAMA DE PÓS GRADUAÇÃO EM ENGENHARIA QUÍMICA

  2010cites this paper
• The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams.

  2010cites this paper
• Drug Safety Evaluation

  2009cites this paper
• Drug-induced hepatotoxicity or drug-induced liver injury.

  2009cites this paper
• Medications for Extensively Drug-Resistant Tuberculosis: Back to the Future?

  2008cites this paper
• Review article: the use of potentially hepatotoxic drugs in patients with liver disease

  2008cites this paper
• Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism.

  2008cites this paper
• Drug-related hepatotoxicity and acute liver failure.

  2008cites this paper
• Analysis of causes that led to rib and skull fractures, sudden illness, intracranial bleeding, and death in the case of toddler Roman Pitts

  2008cites this paper
• Assessing postoperative discomfort after third molar surgery: a prospective study.

  2007cites this paper
• Cholestasis in an elderly patient with pneumonia

  2007cites this paper
• Low-Dose Sultamicillin Versus Amoxicillin-Clavulanic Acid in the Treatment of Acute Bacterial Sinusitis in Adults: A Randomized Clinical Trial

  2007cites this paper
• Antibiotic therapy: a major cause of drug-induced jaundice in southwest England

  2007cites this paper
• Hepatotoxicity due to antibiotics.

  2007cites this paper
• Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.

  2007cites this paper
• Une hépatite cholestatique probable chez une personne âgée sous l’effet de l’imipénem-cilastatine

  2007cites this paper
• Suspected drug-induced destructive cholangitis in a young dog.

  2006cites this paper
• Chapter 26 – Drug-Induced Liver Injury

  2006cites this paper
• Coumarin embryopathy in an extremely low birth weight infant associated with neonatal hepatitis and ocular malformations

  2006cites this paper
• ORAL PENBACTAM IN THE TREATMENT OF ACUTE BACTERIAL SINUSITIS: A RANDOMIZED CLINICAL TRIAL

  2006cites this paper
• Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicity: A prospective series from Spain

  2006cites this paper
• Cholestasis Associated with Ampicillin / Sulbactam Therapy A Case Report

  2006cites this paper
• Incidence of drug-induced liver injury in medical inpatients

  2005cites this paper
• Hepatitis tóxica relacionada con la asociación de amoxicilina y ácido clavulánico

  2005cites this paper
• Kombinace amoxicilinu s kyselinou klavulanovou jako příčina toxického poškození jater

  2005cites this paper
• Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.

  2005cites this paper
• Acute Liver Failure Due To Amoxicillin and Amoxicillin/Clavulanate

  2005cites this paper
• Drug-Induced Liver Disease

  2005cites this paper
• Analysis of causes that led to Eliza Jane Scovill's cardiac arrest and death

  2005influential citation
• Amoxicillina-acido clavulanico ed anticoagulanti orali:un’associazione potenzialmente pericolosa

  2004cites this paper
• Hépatite cholestatique précoce après prise d'amoxicilline-acide clavulanique

  2004cites this paper
• [Cholestasis soon after administration of amoxicillin-clavulanic acid].

  2004cites this paper
• Drug-induced cholestasis

  2003cites this paper
• [Cholestatic hepatitis due to amoxicillin-clavulanic acid with positive re-exposure].

  2003cites this paper
• Hepatotoxicity of antibiotics and antifungals.

  2003cites this paper
• Vanishing bile duct syndrome associated with elevated pancreatic enzymes after short-term administration of amoxicillin.

  2002cites this paper
• Current literature in. Pharmacoepidemiology and drug safety.

  2002cites this paper
• Arzneimittelbedingte Lebererkrankungen

  2002cites this paper
• Rationale for use of antibiotics in periodontics.

  2002cites this paper
• [Drug-induced liver diseases].

  2002cites this paper
• Antibiotic therapy in intra-abdominal infections--a review on randomised clinical trials.

  2001cites this paper
• Antibiotic Induced Endotoxin Release and Clinical Sepsis: a Review

  2001cites this paper